Simmons & Simmons advised Eisai on the divestment. Eisai S.A.S, the French subsidiary of Eisai Co., Ltd., has transferred its rights to Loxapac (loxapine) and Parkinane...
CNX Therapeutics’ €56.5m Acquisition of Eisai’s Rights in Loxapac and Parkinane
FIFA’s Licensing as Payment Institution
Simmons & Simmons has assisted the Fédération Internationale de Football Association on the deal. The Fédération Internationale de Football Association (FIFA) has been licenced by the French...